Organto Foods (OGO) Q1 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2024 earnings summary
8 Jun, 2026Executive summary
First quarter 2024 saw improved loss from operations and net loss, but profitability targets were not met.
Significant restructuring underway, including streamlining product portfolio, refocused marketing, and sale of three subsidiaries.
Businesses retained after subsidiary sales grew sales by 22% year-over-year and generated positive gross profit.
Financial highlights
Sales were $6.7 million, down 11% year-over-year; retained businesses' sales rose 22%, while sold subsidiaries' sales fell 37%.
Gross profit was $0.1 million (2.1% of sales), down from $0.7 million (9.7%) last year; adjusted gross profit was 0.7% of sales.
Cash overhead costs decreased 32% to $1.4 million.
Operating loss was $1.4 million, improved from $1.6 million year-over-year.
Net loss was $1.5 million, improved from $2.0 million last year.
Outlook and guidance
Restructuring of convertible debenture obligations expected to reduce debt and increase flexibility.
Management expects restructuring initiatives to show positive impact in future periods.
Plans to file Q2 and Q3 2024 financial statements on time, aiming to lift the Cease Trade Order.
Latest events from Organto Foods
- Record sales and margin growth in Q1 2026 highlight scalable, efficient organic food operations.OGO
Corporate presentation8 Jun 2026 - Record sales and gross profit in 2023, but net loss widened amid restructuring and higher charges.OGO
Q4 20238 Jun 2026 - Q2 2024 delivered higher sales, net income, and lower overhead following restructuring and asset sales.OGO
Q2 20248 Jun 2026 - Q3 2024 delivered 47% sales growth and a sharply reduced net loss after restructuring.OGO
Q3 20248 Jun 2026 - Record Q4 sales and margin growth highlight strong momentum after restructuring.OGO
Q4 20248 Jun 2026 - Record sales, first positive EBITDA, and improved margins signal strong turnaround momentum.OGO
Q1 20258 Jun 2026 - Record sales and margin gains offset by non-recurring restructuring and debt settlement costs.OGO
Q2 20258 Jun 2026 - Record quarterly sales and gross profit, with strengthened balance sheet and reduced debt.OGO
Q3 20258 Jun 2026 - Record sales and EBITDA, strong balance sheet, and annualized sales surpass EUR 100 million.OGO
Q1 202628 May 2026